Interleukin 6 induction in the canine myocardium after cardiopulmonary bypass

Journal of Thoracic and Cardiovascular Surgery

Volumn 120, Issue 2, 2000, Pages 256-263

  Dreyer, William J ^a   Phillips, Sharon C ^a   Lindsey, Merry L ^a   Jackson, Peggy ^a   Bowles, Neil E ^a   Michael, Lloyd H ^a   Entman, Mark L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DOG; EXTRACORPOREAL CIRCULATION; HEART FUNCTION; HEART PERFUSION; HYPOTHERMIA; NONHUMAN; PRIORITY JOURNAL;

EID: 0033868049     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2000.108168     Document Type: Article

References (30)

1. Complement activation during cardiopulmonary bypass: Evidence for generation of C3a and C5a anaphylatoxins
2. Complement and the damaging effects of cardiopulmonary bypass
3. Complement activation in cardiopulmonary bypass, with special reference to anaphylatoxin production in membrane and bubble oxygenators
4. Upregulation of Mac-1 surface expression on neutrophils during simulated extracorporeal circulation
5. Neutrophil activation and adhesion molecule expression in a canine model of open heart surgery with cardiopulmonary bypass
6. Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators
7. Cytokine and complement levels in patients undergoing cardiopulmonary bypass
8. Elevation of cytokines during open-heart surgery with cardiopulmonary bypass: Participation of interleukin 8 and 6 in reperfusion injury
9. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization
10. Neutrophil adherence to isolated adult cardiac myocytes: Induction by cardiac lymph collected during ischemia and reperfusion
11. Protective effect of interleukin-6 against the death of PC12 cells caused by serum deprivation or by the addition of a calcium ionophore
12. Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL
13. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
14. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: Role of a cytokine-inducible nitric oxide synthase in cardiac myocytes
15. Cardiac myocytes produce IL-6 in culture and in the viable border zone of reperfused infarctions
16. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass
17. Interleukin-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium
18. Hypoxic stress induces cardiac myocyte-derived interleukin-6
19. Resident cardiac mast cells degranulate and release preformed TNF-α, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion
20. Inhibition of nuclear factor κB attenuates proinflammatory cytokine and inducible nitric-oxide synthase expression in postischemic myocardium
21. Adherence of neutrophils to canine cardiac myocytes in vitro is dependent on intercellular adhesion molecule-1
22. Neutrophil induced oxidative injury of cardiac myocytes: A compartmented system requiring CD11b/CD18-ICAM-1 adherence
23. Leukocyte depletion in a neonatal model of cardiac surgery
24. Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction
25. Studies of hypoxemic/reoxygenation injury: Without aortic clamping v role of the L-arginine nitric oxide pathway - The nitric oxide paradox
26. Apoptosis in myocytes in end-stage heart failure
27. Reperfusion injury induces apoptosis in rabbit cardiomyocytes
28. Hypoxia induces apoptosis with enhanced expression of fas antigen messenger RNA in cultured neonatal rat cardiomyocytes
29. Induction of early immediate genes and programmed cell death following cardioplegic arrest in human hearts
30. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway